GLYCINAMIDES AS FACTOR XA INHIBITORS - BRISTOL MYERS SQUIBB CO

Title:

GLYCINAMIDES AS FACTOR XA INHIBITORS

Document Type and Number:

WIPO Patent Application WO2003048081

Kind Code:

A3

Abstract:

The present application describes glycinamidic compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

Inventors:

PINTO DONALD J P (US)
HAN WEI (US)
HU ZILUN (US)

Application Number:

PCT/US2002/037212

Publication Date:

September 12, 2003

Filing Date:

November 18, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

BRISTOL MYERS SQUIBB CO (US)
PINTO DONALD J P (US)
HAN WEI (US)
HU ZILUN (US)
QIAO JENNIFER (US)

International Classes:

A61K31/423; A61P7/02; C07D209/30; C07D209/42; C07D213/75; C07D213/81; C07D295/15; C07D333/38; C07D401/04; C07D413/04; C07D413/14; C07D471/04; (IPC1-7): A61K31/535; A61K31/44; A61K31/52; A61K31/445; A61K31/42; A61K31/40; A61P7/02; C07D207/00; C07D211/00; C07D401/00; C07D403/00

Foreign References:

US6020357A

2000-02-01

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR THE ARYLATION OF OLEFINS

Next Patent: CRYSTALLINE VENLAFAXINE BASE AND NOVEL POLYMORPHS OF VENLAFAXINE HYDROCHLORIDE, PROCESSES FOR PREPAR...